Cargando…
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran
Background: Thalassemia is a chronic, inherited blood disorder, which in its most severe form, causes life-threatening anemia. Thalassemia patients not only engage with difficulties of blood transfusion and iron chelating therapy but also have some social challenges and health threatening factors. T...
Autores principales: | Seyedifar, Meysam, Dorkoosh, Farid Abedin, Hamidieh, Amir Ali, Naderi, Majid, Karami, Hossein, Karimi, Mehran, Fadaiyrayeny, Masoomeh, Musavi, Masoumeh, Safaei, Sanaz, Ahmadian-Attari, Mohammad Mahdi, Hadjibabaie, Molouk, Cheraghali, Abdol Majid, Akbari Sari, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139942/ https://www.ncbi.nlm.nih.gov/pubmed/27928477 |
Ejemplares similares
-
Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System
por: Cheraghali, Abdol Majid
Publicado: (2011) -
Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry
por: Cheraghali, Abdol Majid
Publicado: (2012) -
Blood safety concerns in the Eastern Mediterranean region
por: Cheraghali, Abdol Majid
Publicado: (2011) -
Cost effectiveness of Iran national plasma contract fractionation program
por: Cheraghali, Abdol Majid
Publicado: (2012) -
Impacts of international sanctions on Iranian pharmaceutical market
por: Cheraghali, Abdol Majid
Publicado: (2013)